What is the potential of nanolock- and nanocross-nanopore technology in cancer diagnosis?

Li-Qun Gu; Kent S Gates; Michael X Wang; Guangfu Li

doi:10.1080/14737159.2018.1410060

What is the potential of nanolock- and nanocross-nanopore technology in cancer diagnosis?

Expert Rev Mol Diagn. 2018 Feb;18(2):113-117. doi: 10.1080/14737159.2018.1410060. Epub 2017 Dec 1.

Authors

Li-Qun Gu¹, Kent S Gates², Michael X Wang³, Guangfu Li⁴

Affiliations

¹ a Department of Bioengineering and Dalton Cardiovascular Research Center , University of Missouri , Columbia , MO , USA.
² b Department of Chemistry and Department of Biochemistry , University of Missouri , Columbia , MO , USA.
³ c Department of Pathology and Immunology , Washington University School of Medicine , St. Louis , MO , USA.
⁴ d Department of Surgery and Ellis Fischel Cancer Center , University of Missouri , Columbia , MO , USA.

No abstract available

Keywords: Cancer diagnostics; Point-of-care; Precision medicine; biosensor; driver mutation; nanocross; nanolock; nanopore; precision oncology; single nucleotide polymorphism (SNP).

Publication types

Editorial
Research Support, N.I.H., Extramural
Review

MeSH terms

Biosensing Techniques / methods
Biosensing Techniques / standards
DNA Mutational Analysis / methods
Humans
Mutation
Nanotechnology* / methods
Neoplasms / diagnosis*
Neoplasms / genetics
Polymorphism, Single Nucleotide
Theranostic Nanomedicine* / methods
Theranostic Nanomedicine* / standards

Publication types

MeSH terms

Grants and funding